Elite Pharmaceuticals Inc (OTCBB - OTCQB:ELTP)

0.3212
Data as of Sep 30
 -0.0088 / -2.67%
Today’s Change
0.09
Today|||52-Week Range
0.97
+167.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$184.6M

Company Description

Elite Pharmaceuticals, Inc. is a pharmaceutical company, which is specialized in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders. Its primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection. Elite Pharmaceuticals was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Contact Information

Elite Pharmaceuticals, Inc.
165 Ludlow Avenue
Northvale New Jersey 07647
P:(201) 750-2646
Investor Relations:
(518) 398-6222

Employees

Shareholders

Individual stakeholders24.48%
Mutual fund holders0.19%
Other institutional0.02%

Top Executives

Nasrat A. HakimPresident, Chief Executive Officer & Director
Doug PlasscheExecutive Vice President-Operations
Carter J. WardChief Financial Officer, Secretary & Treasurer
Ashok G. NigalayeDirector & Chief Scientific Officer
Dianne WillHead-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.